{"transactions":[{"id":3416320,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":155026,"kind":"person","name":"Hall Samuel W.","position":1,"cik":"0001780090","reported_name":"Hall Samuel W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-09-13T00:10:16.000Z","date":"2019-09-10","kind":"grant","acquired":true,"shares":29555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest (i) 1/12th of the total shares on June 21, 2019; and then (ii) quarterly as to 1/12th of the total shares, commencing the first quarter following June 21, 2019, subject to Reporting Person's continued service through each vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Apple Tree Life Sciences, Inc. (the \"Manager\"), the Reporting Person holds the option for the benefit of Apple Tree Partners IV, L.P. (the \"Fund\").   The Reporting Person is obligated to turn over to the Manager any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund to the Manager. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":29555,"derivative":{"exercise_price":28.8,"expiration_date":"2029-09-09","underlying":"Common Stock","underlying_shares":29555},"source":{"system":"sec-edgar","filing":"0001567619-19-018224","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000156761919018224/doc1.xml","form_type":"4"}}]}